A long-acting amylin analogue — the newest addition to the metabolic line. 5mg per vial.
Cagrilintide is a synthetic, long-acting analogue of amylin — the 37-amino-acid hormone the pancreas releases alongside insulin. The molecule carries a fatty-acid chain that binds it to albumin in circulation, which is what gives it a half-life long enough to sit in the extended-release generation of metabolic peptides. It is commonly researched on its own and, in the published literature, in combination with GLP-1 analogues, which is where most of the current interest sits. The newest addition to the metabolic line. Supplied as 5mg of freeze-dried powder per vial, for reconstitution with bacteriostatic water; store at 2–8°C.